The global infection control market is expected to grow approximately 6 percent annually from $10.5 billion in 2012 to $14 billion by 2017, according to a MarketsandMarkets report.
The report looks at sterilization (heat, chemical, radiation and filtration) and disinfection (disinfectors, endoscope reprocessing, disinfectants, medical non-wovens and disinfectant wipes) technologies. In addition, the report presents data on sterilization services market, including hospital sterilization services, and sterilization applications market, including medical devices and food.
MarketsandMarkets identified at least six factors driving infection control market growth:
• Increased pressure for sterilized and disinfected medical devices in hospitals and clinics.
• Increased awareness of food quality and exports of exotic fruits and vegetables across countries.
• Introduction of technically enhanced instruments in the market like endoscopes and analyzers.
• Continued instrument development and increasing minimally invasive surgery procedures.
• Increased use of single-use technology products like medical non-wovens and face masks.
• Stringent regulatory requirements.
5 Predictors of Infection From Antibiotic-Resistant Strain of E. Coli
Study: Nearly One-Third of Antimicrobial Use Among Dialysis Patients is Inappropriate
The report looks at sterilization (heat, chemical, radiation and filtration) and disinfection (disinfectors, endoscope reprocessing, disinfectants, medical non-wovens and disinfectant wipes) technologies. In addition, the report presents data on sterilization services market, including hospital sterilization services, and sterilization applications market, including medical devices and food.
MarketsandMarkets identified at least six factors driving infection control market growth:
• Increased pressure for sterilized and disinfected medical devices in hospitals and clinics.
• Increased awareness of food quality and exports of exotic fruits and vegetables across countries.
• Introduction of technically enhanced instruments in the market like endoscopes and analyzers.
• Continued instrument development and increasing minimally invasive surgery procedures.
• Increased use of single-use technology products like medical non-wovens and face masks.
• Stringent regulatory requirements.
More Articles on Infection Control:
NQF Endorses Infectious Disease, Neurological, Pulmonary Measures5 Predictors of Infection From Antibiotic-Resistant Strain of E. Coli
Study: Nearly One-Third of Antimicrobial Use Among Dialysis Patients is Inappropriate
